Monitoring [hlca]
Lipids [lipd]
Enzymes [enzy, orch]
Creatine Kinase [aapp, enzy]
Patients [podg]
Lipid-lowering therapy [topp]
Drug [phsu]
plasma lipid [lbpr]
Parameters [fndg]
Estimate [qnco]
CARDIOVASCULAR [bdsy]
Target [ftcn]
treatment [ftcn]
Algorithms [inpr]
Based [ftcn]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
intervention trials [resa]
Targeted [ftcn]
Measures [qnco]
Cases [ftcn]
Calculation [acty]
Alternative [cnce]
treatment [ftcn]
Target [ftcn]
Apolipoprotein B [aapp, bacs]
High Density Lipoprotein Cholesterol [bacs, lipd]
Lipid [lipd]
Measure [qnco]
Contribute [acty]
risk analysis [qlco]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
lipoprotein-associated phospholipase A(2) [aapp, enzy]
primary treatment [topp]
Target [ftcn]
CARDIOVASCULAR [bdsy]
Prevention [topp]
Alternative [cnce]
Target [ftcn]
Apo-B [aapp, bacs]
High Density Lipoprotein Cholesterol [bacs, lipd]
Select [acty]
High Risk [qlco]
CARDIOVASCULAR [bdsy]
Triglycerides [bacs, lipd]
Targeted [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Lp(a) [aapp, bacs]
Ratios [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Apo-B [aapp, bacs]
Apo A-1 [aapp, bacs]
Recommended [idcn]
treatment [ftcn]
Target [ftcn]
Lipids [lipd]
monitor [hlca]
Titration [lbpr]
Target [ftcn]
Lipids [lipd]
Checked [acty]
Frequently [tmco]
treatment [ftcn]
Adherence [ftcn]
Indicated [fndg]
Monitoring [hlca]
Muscle [tisu]
Liver enzymes [aapp, enzy]
Start [tmco]
treatment [ftcn]
Stable [qlco]
condition [dsyn]
treatment [ftcn]
Focus [spco]
symptoms [ftcn]
alert [fndg]
Muscle [tisu]
hepatic complications [patf]
Routine [qlco]
Measurement [ftcn]
treatment [ftcn]
Statins [orch, phsu]
